
Histogen
Regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor.
Market cap
$1.3m
Enterprise value
($3m)
Share price
$0.01 HSTO
Authorizing premium user...
Regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor.